Laskawi, Raíner

[["dc.bibliographiccitation.artnumber","1"],["dc.bibliographiccitation.journal","Head & Face Medicine"],["dc.bibliographiccitation.volume","6"],["dc.contributor.author","Ellies, Maik"],["dc.contributor.author","Laskawi, Rainer"],["dc.date.accessioned","2018-11-07T08:47:45Z"],["dc.date.available","2018-11-07T08:47:45Z"],["dc.date.issued","2010"],["dc.description.abstract","Background: Diseases of the salivary glands are rare in infants and children (with the exception of diseases such as parotitis epidemica and cytomegaly) and the therapeutic regimen differs from that in adults. It is therefore all the more important to gain exact and extensive insight into general and special aspects of pathological changes of the salivary glands in these age groups. Etiology and pathogenesis of these entities is still not yet fully known for the age group in question so that general rules for treatment, based on clinical experience, cannot be given, particularly in view of the small number of cases of the different diseases. Swellings of the salivary glands may be caused by acute and chronic inflammatory processes, by autoimmune diseases, by duct translocation due to sialolithiasis, and by tumors of varying dignity. Clinical examination and diagnosis has also to differentiate between salivary gland cysts and inflammation or tumors. Conclusion: Salivary gland diseases are rare in childhood and adolescence. Their pattern of incidence differs very much from that of adults. Acute and chronic sialadenitis not responding to conservative treatment requires an appropriate surgical approach. The rareness of salivary gland tumors is particularly true for the malignant parotid tumors which are more frequent in juvenile patients, a fact that has to be considered in diagnosis and therapy."],["dc.identifier.doi","10.1186/1746-160X-6-1"],["dc.identifier.isi","000208595100001"],["dc.identifier.pmid","20156335"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/5693"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/21038"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Biomed Central Ltd"],["dc.relation.issn","1746-160X"],["dc.rights","CC BY 2.0"],["dc.rights.uri","https://creativecommons.org/licenses/by/2.0"],["dc.title","Diseases of the salivary glands in infants and adolescents"],["dc.type","review"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","1"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Head & Face Medicine"],["dc.bibliographiccitation.lastpage","5"],["dc.bibliographiccitation.volume","3"],["dc.contributor.author","Junghans, Katharina"],["dc.contributor.author","Rohrbach, Saskia"],["dc.contributor.author","Ellies, Maik"],["dc.contributor.author","Laskawi, Rainer"],["dc.date.accessioned","2021-06-01T10:48:01Z"],["dc.date.available","2021-06-01T10:48:01Z"],["dc.date.issued","2007"],["dc.description.abstract","Background: Facial pain syndromes can be very heterogeneous and need individual diagnosis and treatment. This report describes an interesting case of facial pain associated with eczema and an isolated dyskinesia of the lower facial muscles following dental surgery. Different aspects of the pain, spasms and the eczema will be discussed."],["dc.description.abstract","Case presentation: In this patient, persistent intense pain arose in the lower part of her face following a dental operation. The patient also exhibited dyskinesia of her caudal mimic musculature that was triggered by specific movements. Several attempts at therapy had been unsuccessful. We performed local injections of botulinum toxin type A (BTX-A) into the affected region of the patient's face. Pain relief was immediate following each set of botulinum toxin injections. The follow up time amounts 62 weeks."],["dc.description.abstract","Conclusion: Botulinum toxin type A (BTX-A) can be a safe and effective therapy for certain forms of facial pain syndromes."],["dc.identifier.doi","10.1186/1746-160X-3-32"],["dc.identifier.fs","201926"],["dc.identifier.ppn","559812132"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/4369"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/85799"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-425"],["dc.notes.intern","Merged from goescholar"],["dc.relation.eissn","1746-160X"],["dc.relation.issn","1746-160X"],["dc.relation.orgunit","Universitätsmedizin Göttingen"],["dc.rights","Goescholar"],["dc.rights.uri","https://goescholar.uni-goettingen.de/licenses"],["dc.subject.ddc","616"],["dc.title","Improvement of chronic facial pain and facial dyskinesia with the help of botulinum toxin application"],["dc.title.alternative","Case report"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]